Oramed Pharmaceuticals Inc. — Director's Dealing 2014

Apr 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2014-04-09

Reporting Person: KIDRON NADAV (Director, President and CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-09	Stock Option (right to buy)	$12.45	A	47134	Acquired	2024-04-09	Common Stock (47134)	Direct

Footnotes

F1: The Stock Option will vest with respect to 15,710 shares on April 30, 2014 and with respect to 3,928 shares on the last day of each month thereafter.